TORNTPHARM | TECHNO-FUNDA ANALYSIS

Torrent Pharmaceuticals Ltd – 1W

Trend: Strong uptrend with healthy consolidation. The stock has given a fresh breakout and is currently retesting its previous resistance zone, now acting as support. Price action remains bullish as long as it sustains above ₹3,485. Key Levels: Tested Demand / Support: ₹2,888 Retest Level: ₹3,485 Fresh Breakout Level: ₹3,786 Fundamentals (Key Points): 💊 Leading pharma company with a diversified portfolio in chronic therapies like cardiology, diabetology, and CNS. 🌍 Strong domestic presence with growing international business, especially in the U.S. and Brazil. 📈 Healthy financials with consistent revenue growth and robust operating margins. ⚙️ Focused on R&D and product launches across key regulated markets. 💵 Low debt-to-equity and consistent dividend payer reflecting strong financial discipline. Final Verdict: Bullish — Sustaining above ₹3,485 keeps momentum intact. A breakout above ₹3,786 can trigger the next leg toward ₹4,100+. Fundamentally solid and technically strong — ideal for medium to long-term accumulation.